EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type I Interferon Signaling Augments Autoimmunity in Neuromyelitis Optica Spectrum Disorder

Tian-Xiang Zhang iD, Xiaoxiao Yang, Xue Gao iD, Xiaoshan Du, Xuegan Lian, Naiyuan Shao, Ye Liu, Zhenning Huang, Dongmei Jia, Alexander Y L Lau, Zhiguo Li, Zaal Kokaia und 2 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202500942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Tian-Xiang Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tianjin Medical University General Hospital, Tianjin, 300052, China. Hauptthemen laut MEDLINE: Neuromyelitis Optica, Autoimmunity, Signal Transduction, Interferon Type I. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation of China, Tianjin Health Research Project, Tianjin Public Health Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease characterized by anti‐aquaporin 4 (AQP4) antibody‐mediated astrocyte damage and subsequent demyelination. Prior attempts to treat NMOSD with interferon‐beta (IFN‐β), a disease‐modifying therapy for multiple sclerosis, resulted in worsening of disease activity, with an unknown mechanism. Here, robust activation of the cGAS‐STING‐IFN‐I signaling pathway is identified in myeloid cells in both the periphery and central nervous system. The abnormal IFN‐I response gives rise to an increase in the number of AQP4 antigen‐specific autoreactive T cells. Sting deficiency can significantly blunt the activation of AQP4‐specific T cells, as well as the IFN‐I activity in microglia, and attenuate astrocyte damage. Consequently, the clinical manifestation of NMOSD is ameliorated in a passive transfer mouse model of NMOSD. Further, treatment with STING inhibitor H151 alleviates the severity of NMOSD mouse models. These findings uncover the cGAS‐STING‐IFN‐I pathway in promoting autoreactive T cells and establish a foundation for inhibiting this pathway as a new therapeutic revenue for NMOSD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromyelitis OpticaAutoimmunitySignal TransductionInterferon Type IAnimalsMiceDisease Models, AnimalHumansAquaporin 4Mice, Inbred C57BLMembrane Proteins

Stichwörter der Autor:innen

T cellsinnate immune responseneuromyelitis optica spectrum disordertype I interferon

Substanzen

Interferon Type IAquaporin 4Membrane Proteins

Autor:innen und Institutionen

  • Department of Neurology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
  • Department of Bioinformatics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
  • Department of Neurology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, China.
  • Department of Neurosurgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, China.
  • Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, 999077, China.
  • Laboratory of Stem Cells and Restorative Neurology, Lund Stem Cell Center, Lund University, Lund, 22184, Sweden.

ORCID-Profile: Tian-Xiang Zhang, Xue Gao, Fu-Dong Shi, Chao Zhang

Förderung

  • National Science Foundation of China
  • Tianjin Health Research Project
  • Tianjin Public Health Science and Technology Major Project
  • Peking Union Medical College
  • Natural Science Foundation of Tianjin Municipal Science and Technology Commission
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, T. X., Yang, X., Gao, X., Du, X., Lian, X., Shao, N., Liu, Y., Huang, Z., Jia, D., Lau, A. Y. L., Li, Z., Kokaia, Z., Shi, F. D., & Zhang, C. (2025). Type I Interferon Signaling Augments Autoimmunity in Neuromyelitis Optica Spectrum Disorder. Advanced Science. https://doi.org/10.1002/advs.202500942

Vancouver

Zhang TX, Yang X, Gao X, Du X, Lian X, Shao N, et al. Type I Interferon Signaling Augments Autoimmunity in Neuromyelitis Optica Spectrum Disorder. Advanced Science. 2025. doi:10.1002/advs.202500942

BibTeX
@article{Zhang2025,
  author = {Zhang, Tian-Xiang and Yang, Xiaoxiao and Gao, Xue and Du, Xiaoshan and Lian, Xuegan and Shao, Naiyuan and Liu, Ye and Huang, Zhenning and Jia, Dongmei and Lau, Alexander Y L and Li, Zhiguo and Kokaia, Zaal and Shi, Fu-Dong and Zhang, Chao},
  title = {Type I Interferon Signaling Augments Autoimmunity in Neuromyelitis Optica Spectrum Disorder},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202500942}
}
Kostenlos starten →